Inflammatory bowel disease (lED) in children remains a challenging problem. Crohn disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders of the gastrointestinal tract. There is increasing immunologic and genetic evidence to suggest that CD and UC are different diseases. Once inflammation begins, however, many common secondary pathways of inflammation are initiated. While the specific causes of these diseases remain elusive, the inflammatory cytokines appear to play an important role in disease pathogenesis (1) .
CD and UC are characterized by an activation of intestinal mononuclear cells and T-cells within the lesions of inflammation (2) . It is now recognized that physical interaction between antigen-presenting cells (mononuclear) and T-cells is promoted by cell-to-cell adhesion molecules of the immunoglobulin-super and integrin families. These adhesion molecules, which are induced early during immune activation, traverse the cell membranes and link the intracellular matrices of the interacting immune cells with the extracellular environment. Some of these T-lymphocytes synthesize and secrete interleukin 2 (lL-2) after activation by an antigen or mitogen. IL-2 acts as a growth factor for mature T cells as well as thymocytes and induces T lymphocyte cytotoxicity. It exerts its effects by interacting with specific receptors which have been demonstrated on activated T cells, B cells and monocytes. Activated T cells shed interleukin-2 receptors (lL-2R) in a soluble form (sIL-2R) which can be detected in the blood. The sIL-2R is a useful, non-specific marker of in vivo activated cellular immune functions (3) . There is an increase in mucosal lymphocyte and macrophage populations in active UC and CD. Increased numbers ofintestinal cells expressing IL-2Rs and T-cells bearing activation antigens have been demonstrated in active CD (4) .
The aim of the present study was to determine whether circulating inflammatory mediators, such as interleukins and adhesion molecules, represent useful markers of immune activation in vivo and to characterize their respective roles in monitoring activity in lED.
MATERIALS AND METHODS

Patients
Eight patients with active CD (5 boys and 3 girls, 11-17, mean age IS years), 10 patients with active DC (6 boys and 4 girls, 6-14, mean age 12 years) and 25 healthy subjects matched for age and sex were investigated. Diagnosis of CD and DC were made by conventional clinical, radiological, endoscopic and histopathological criteria. CD and DC disease activity was determined using the criteria described by Hyams and Truelove, respectively (5, 6) . Subjects manifesting an intercurrent viral or bacterial illness within 10 days from the visit to the clinic were excluded from the study. The protocol was reviewed by the Scientific Ethics Committee. Informed consent was obtained from the parents or patients before enrollment. The study was conducted according to the Helsinki declaration.
Sera
Sera were separated within IS min of venipuncture by centrifugation at 1000 g for 10 min at 4°C. The sera were promptly aliquoted and frozen at -80" C until further use. Serum concentrations of IL-2, IL-6, IL-8, IL-IO. sIL-2R, sICAM-I andsVCAM-l were measured by a quantitative enzyme -linked immunosorbent kit (ELISA; Quantikine; R&D Systems, Mineapolis, Minessota). This commercially available kit uses a quantitative "sandwich" technique on patient serum samples. Briefly, a monoclonal antibody specific for the cytokine tested was coated onto a microtiter plate.
Standard amount of the cytokine tested and patient samples were added to the wells, and any cytokine present was bound by the immobilized antibody. After washing away the unbound protein, an enzyme-linked polyclonal antibody specific for the cytokine tested was added to the wells tovsandwich'' the cytokine captured by the first incubation. Substrate solution for the enzyme was then added to the wells, and color developed in proportion to the amount of the cytokine in the initial step. Dsing optical density values determined by a standard curve, the concentration of the cytokine tested in the unknown sample was determined. According to the manufacturer's specifications. This assay recognizes natural and recombinant cytokines separately, with no cross reactivity to other cytokines. All samples were run in duplicate.
Serum C-reactive protein (CRP) concentration was determined by nephelometry (Behringwerke AG, Marbutg, Germany). Values >0.5 mg/dl were positive.
Statistical Analysis
Results are expressed as mean ± SE . Group mean differences were evaluated with the unpaired Student's t test. Differences in proportions were assessed with the x' test. The Pearsons ' correlation coefficient (I') was calculated to assess the degree of linear correlation among the different cytokine, soluble molecules and CRP values.
RESULTS
Pro-inflammatory mediators, IL-6, IL-8 and IL-I 0, were elevated in the serum of patients with CD and UC as compared to the control group. IL-6 mean values were 49±5 pg/ml in CD, 39±4 pg/ ml in UC and 9±2 pg/ml in the control group. IL-6 values were statistically significantly higher in CD and DC as compared to the control group (p<O.OOI) ( Fig. I ) . IL-8 mean values were 245±39 pg/ml in CD, I 98±24 pg/ml in UC, and 23±9 pg/ ml in the controls. Significantly higher IL-8 values were noted in CD and UC as compared to the control group (p<O.OOI) (Fig.2) . The mean serum concentrations of IL-I 0 were significantly higher in CD (167±25 pg/ml) and UC (138±28 pg/ml) than those of the control group (41 ±7pg/ml) (p<O.OOI) ( Fig.3) .
IL-2 mean values were I 08±12 pg/ml in CD, 80±24 pg/ml in UC and 15±3 pg/ml in the control group. Significantly higher IL-2 values were noted in CD and UC as compared to the control group p<O.OOI (FigA) . 
Tab. I. Correlation between all cytokines and soluble molecules.
The mean serum concentrations of sIL-2R was 5518±415 U/ml in CD, 3778±790 U/ml in UC and 984±85 U/ml in the control group. There was statistically significant difference between CD and UC values as compared to the control group (p-ctl.Ol) (Fig.5 ). The mean serum concentrations of sICAM-l were l632±116 U/ml in CD, 852±34 U/ml in UC and 254±18 U/ml in the control group. The sICAM-l values were higher in CD and UC as compared to the control group (p<O.OO 1) (Fig. 5 ). The mean values of sVCAM-l were 2086±153 U/ml in CD, 1459+127 U/mlin UC and 576±27 U/ml in the control group. The sVCAM-1 values were higher in CD and UC as compared to the control group (p<0.01) ( Fig. 5 ).
There is no statistically significant difference among the above parameters between CD and uc.
Correlations among the above cytokines, soluble molecules as well as CRP are presented in Tab. 1.
DISCUSSION
The acute phase response of intestinal inflammation was investigated in this study. Inflammatory cytokines as well as the soluble molecules measured were elevated in active CD and uc. There was statistically significant difference of these values and those of the control group.
The relationship of serum IL-6 with the acute phase response has recently been examined in a variety of acute and chronic inflammatory conditions (7) . Elevated circulating IL-6 is common in CD and UC and may reflect clinical activity and acute phase response. Laboratory expression of acute phase response is frequently more pronounced in patients with CD than in those with UC (8) . IL-6 is a potent in vitro stimulant for the production of acute phase proteins by the liver (9) . It is not unexpected that we found higher serum IL-6 values in patients with CD and UC as compared to the normal group. The IL-6 values tended to be higher in CD than in UC but the differences did not reach statistical significance. IL-8 has multiple functions in the development of the inflammatory response and it is believed to be important in the hemodynamic disturbances of inflammation (10) . According to our data, IL-8 values were elevated in CD and UC. This finding may suggest that IL-8 may be involved in the inflammatory process in IBD. Similar findings have been reported by others (11).
CD and UC patients in this study had significantly increased IL-l 0 serum concentrations as compared to the control group. Circulating antiinflammatory cytokine IL-l 0 was also found elevated by other investigators, suggesting that IL-10 acts as a naturally occurring damper in the acute inflammatory process of IBD (12) . The production of IL-10 in humans is reported to be under genetic control and genotype defines high or low producers (13) . Individuals genetically predisposed to produce less IL-10 are at higher risk of developing IBD, in particularUC (13) . The above report does not agree with previous observations regarding IL-l 0 which did not appear to contribute to the risk of developing UC or CD (14) . Our data argue against a general deficiency in IL-10 production in IBD. The results suggest that the local production ofIL-l 0 may be insufficient to down regulate pro-inflammatory cytokines. This is also supported by other investigators (15, 16) . This favors the potent clinical utility of combined treatment and improving the chances of developing effective treatments for human IBD (17) . The administration of IL-10, a contrainflammatory cytokine, which downregulates immune activation may induce improvement in IBD patients (18) . Both pro inflammatory and antiinflammatory cytokines are up-regulated in IBD and influence each other. Systemic or topical applications of combined cytokine treatment might be a new effective therapeutic approach (19) .
Raised concentrations of serum sIL-2R in patients with active CD and UC in this study is further evidence of in vivo immune activation and an indication of disease activity in IBD with a potential advantage over other laboratory parameters currently available in that it may reflect more accurately the underling immunopathogenic process (3, 20, 21) . Measurement of sIL-2R may be a useful adjunct to clinical assessment and routine laboratory testing.
This study shows that cell-to-cell adhesion molecules, such as ICAM-l and VCAM-l, can be detectedina soluble form (sICAM-l and sVCAM-1) in the serum of patients with active IBD. Their concentrations in CD and UC are higher than those in the control group. Higher circulating levels are present in patients with active CD than those with U'C. However, the differences do not reach statistical significance. These findings are in agreement with those by others (22, 23, 24) . Elevated sICAM-I levels in active CO and UC may reflect increased adhesiveness and signal transmission across cell membranes in vivo, probably as a result of ongoing local cellular immune responses (25) . These data, indicating abnormalities in cell-to-cell adhesion molecules in vivo, raises the interest for the development of new antiinflammatory substances, such as antibodies to adhesion molecules themselves, which may compete with cellular ICAM-l. Such antibodies have been shown to inhibit T cell mediated injury in vivo, suggesting that ICAM-l probably plays a critical pathogenetic role in this process (18) .
In summary, according to the present study, all the inflammatory mediators are increased in patients with lBO, both CO and UC, suggesting a role of cytokines and adhesion molecules in the inflammatory process in IBO. The measurement of all these mediators may be useful adjuncts to clinical assessment and routine laboratory testing in IBO patients. Serial levels may be predictive of the clinical course and response to therapy. Several cytokines have been investigated in IBO (26) (27) (28) (29) . The present study contributes to the literature with the measurement of a number of inflammatory mediators, five cytokines (IL-2, IL-6, IL-8, IL-10) (30) and three soluble molecules (sIL-2R, sICAM-l, sYCAM-l) simultaneously at the time of exacerbation of the disease and the comparison of these parameters with those of healthy subjects who served as controls as well as with objective markers of immunoinflammatory stimulation cell activation as C-reactive protein. These data contribute to further understanding of the inflammatory pathophysiology of IBO. The measurment of the above parameters may be helpful in the assessment and follow up of children with IBO.
